Genital Bleeding during the Administration of Danazol
Gen‐ichi Nakamura, Kiyotaka Yoshimitsu, Mutsunori Imura, Hitoo Nakano
Abstract
Gen‐ichi Nakamura, Kiyotaka Yoshimitsu, Mutsunori Imura, Hitoo Nakano
Abstract
Abstract In an effort to reduce undesirable bleeding during danazol treatment, we attempted to see any correlation between the frequency of bleeding and the starting period of danazol treatment during the menstrual cycle. We studied 57 women who were suffering from endometriosis externa and given danazol (400 mg/day) for periods between 16 and 24 weeks. The patients were divided into 4 groups depending on the day administration of the drug began; 18 patients started on the 1st or 2nd day of the menstrual cycle, 12 on the 3rd day, 20 on the 5th day and 7 after the 10th day. The rate of bleeding was 6.8±6.3% (M±SD) in the group starting on the 1st or 2nd day. This was significantly smaller than that of other groups starting treatment later in the menstrual cycle. The number of patients with complete amenorrhea throughout the entire treatment period was significantly higher in the group beginning administration of danazol on the 1st or 2nd day of the menstrual cycle. Therefore, administration of danazol should be started as early as possible in the menstrual cycle to reduce the frequency of bleeding.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract In an effort to reduce undesirable bleeding during danazol treatment, we attempted to see any correlation between the frequency of bleeding and the starting period of danazol treatment during the menstrual cycle. We studied 57 women who were suffering from endometriosis externa and given danazol (400 mg/day) for periods between 16 and 24 weeks. The patients were divided into 4 groups depending on the day administration of the drug began; 18 patients started on the 1st or 2nd day of the menstrual cycle, 12 on the 3rd day, 20 on the 5th day and 7 after the 10th day. The rate of bleeding was 6.8±6.3% (M±SD) in the group starting on the 1st or 2nd day. This was significantly smaller than that of other groups starting treatment later in the menstrual cycle. The number of patients with complete amenorrhea throughout the entire treatment period was significantly higher in the group beginning administration of danazol on the 1st or 2nd day of the menstrual cycle. Therefore, administration of danazol should be started as early as possible in the menstrual cycle to reduce the frequency of bleeding.
Key concepts: Danazol, Menstrual cycle, Medicine, Endometriosis, Menstruation, Amenorrhea, Menstrual bleeding, Menstrual period